[Clinical researchers and the pharmaceutical industry].
The diminished financial support by the government of clinical investigation has led to clinical units that depend for their infrastructure largely on contract research for the pharmaceutical industry. This poses a threat to the independence of scientific research, to the freedom to publish scientific results and to the continuity of the research. Moreover, it is not easy for a researcher to retain a position of integrity and independence in the face of a jungle of conflicting interests and not to let personal interests prevail. The difficult relation between the physician and the pharmaceutical industry is the subject of a forthcoming short series of articles.
Afd. Inwendige Geneeskunde, Academisch Medisch Centrum/Universiteit van Amsterdam.
J W
JW
ten Cate
D002170:Canada; D016265:Conflict of Interest; D003284:Contract Services / Q000592:standards / Q000639:trends*; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000639:trends*; D006801:Humans; D018973:Intellectual Property; D016365:Liability, Legal; D009426:Netherlands; D011643:Publishing / Q000331:legislation & jurisprudence; D012106:Research / Q000331:legislation & jurisprudence / Q000592:standards* / Q000639:trends*; D015871:Scientific Misconduct / Q000145:classification / Q000639:trends
Klinisch onderzoekers en farmaceutische industrie.